NovAb is a biotechnology company developing therapeutic drugs, diagnostic reagents, and biomedical research reagents.
NovAb has raised $460K in total funding. The most recent round was Debt Financing. The last funding was announced in February 2025.
NovAb is headquartered in Tucker, United States.
NovAb is a biotechnology company developing therapeutic drugs, diagnostic reagents, and biomedical research reagents.
NovAb is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NovAb — Funding & Investors." VCBacked, February 11, 2025, https://www.vcbacked.co/company/novab. Accessed August 13, 2026.
VCBacked. (2025). NovAb — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/novab
{{cite web |title=NovAb — Funding & Investors |url=https://www.vcbacked.co/company/novab |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated